Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shandong Pharmaceutical Glass Co (SHSE:600529) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Shandong Pharmaceutical Glass Co Forward PE Ratio Related Terms
Shandong Pharmaceutical Glass Co Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co Forward PE Ratio Chart
Shandong Pharmaceutical Glass Co Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
14.66
12.60
Shandong Pharmaceutical Glass Co Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
2026-06
Forward PE Ratio
14.66
13.60
14.46
13.18
12.60
13.54
13.74
SHSE:600529 vs SW, AMCR, PKG: Forward PE Ratio Comparison
For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Pharmaceutical Glass Co Forward PE Ratio vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Shandong Pharmaceutical Glass Co's Forward PE Ratio falls into.
Shandong Pharmaceutical Glass Co Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Shandong Pharmaceutical Glass Co (SHSE:600529) has a Forward PE Ratio of 13.88 as of Sep. 02, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Shandong Pharmaceutical Glass Co and its competitors. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #60 out of 113 companies in the Packaging & Containers industry, placing it in the top 53.1%.
Is Shandong Pharmaceutical Glass Co's Forward PE Ratio too high?
Shandong Pharmaceutical Glass Co's current Forward PE Ratio is 13.88. The Packaging & Containers industry median Forward PE Ratio is 13.52. Shandong Pharmaceutical Glass Co's value of 13.88 is 2.7% above this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #60 out of 113 companies in the Packaging & Containers industry, which is below the industry midpoint. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's Forward PE Ratio compare to SW and AMCR?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #60 out of 113 companies for Forward PE Ratio. This places Shandong Pharmaceutical Glass Co in the lower half of its industry. The industry median Forward PE Ratio is 13.52. Shandong Pharmaceutical Glass Co's value of 13.88 is 2.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Packaging & Containers company?
The median Forward PE Ratio among Packaging & Containers companies is 13.52, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current Forward PE Ratio of 13.88 is 2.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Shandong Pharmaceutical Glass Co and its competitors. For the Packaging & Containers industry, the median Forward PE Ratio is 13.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current Forward PE Ratio is 13.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.61, compared to a current price of ¥19.02 — trading 19.4% below its estimated fair value. The current Forward PE Ratio is 13.88 and 2.7% above the Packaging & Containers industry median of 13.52. Shandong Pharmaceutical Glass Co's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current Forward PE Ratio is 13.88 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥19.02 is trading 19.4% below its estimated GF Value™ of ¥23.61.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
Forward PE Ratio: 13.88
GF Value™: ¥23.61 vs. price of ¥19.02 (19.4% below fair value)
Industry Position: 2.7% above the Packaging & Containers median (#60 of 113)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
93GF Score
Get the complete analysis for SHSE:600529
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
